Table 1.
Completed IPT (n = 1230) | Did not complete IPT (225) | P-value | |
---|---|---|---|
Male | 742 (85%) | 133 (15%) | 0.73 |
Female | 488 (84%) | 92 (16%) | |
Median age (IQR) | 42 (34, 49) | 39 (32, 47) | 0.01 |
Median CD4 cell count (IQR) | 527 (368, 729) | 491 (306, 710) | <0.03 |
Receiving HAART at time of IPT | 846 (87%) | 125 (13%) | <0.01 |
Not receiving HAART at time of IPT | 384 (79%) | 100 (21%) | |
Mean time on HAART (months) | 52.5 | 50.5 | 0.55 |
Median (IQR) time on HAART (months) | 49 (25, 78) | 42 (18, 74) | 0.39 |
IPT, isoniazid preventive therapy; IQR, interquartile range.